Urologic Neoplasms/radiotherapy; Brachytherapy; Combined Modality Therapy; Controlled Clinical Trials as Topic; Cystectomy; Data Interpretation, Statistical; Dose Fractionation, Radiation; Female; Humans; Kidney/pathology; Kidney Neoplasms/mortality; Kidney Neoplasms/pathology; Kidney Neoplasms/radiotherapy; Kidney Neoplasms/surgery; Male; Meta-Analysis as Topic; Neoplasm Staging; Nephrectomy; Organ Preservation; Prospective Studies; Radiotherapy Dosage; Radiotherapy, Adjuvant; Retrospective Studies; Survival Analysis; Time Factors; Ureter/pathology; Ureteral Neoplasms/drug therapy; Ureteral Neoplasms/mortality; Ureteral Neoplasms/pathology; Ureteral Neoplasms/radiotherapy; Urethra/pathology; Urethral Neoplasms/drug therapy; Urethral Neoplasms/mortality; Urethral Neoplasms/pathology; Urethral Neoplasms/radiotherapy; Urinary Bladder/pathology; Urinary Bladder Neoplasms/pathology; Urinary Bladder Neoplasms/radiotherapy; Urinary Bladder Neoplasms/surgery; Urologic Neoplasms/drug therapy; Urologic Neoplasms/mortality; Urologic Neoplasms/pathology; Urologic Neoplasms/surgery